Skip to main navigation menu Skip to main content Skip to site footer

Narrative Review

Vol. 10 No. 2 (2007)

Asbestos: mining exposure, health effects and policy implications

  • Kristina Luus
November 1, 2020


The purpose of this paper is to review research in the health effects and risks associated with exposure to asbestos and then to use this scientific evidence to analyze the implications of Canada's current policy on the use, manufacturing and export of asbestos. The review begins with a brief historical introduction to asbestos, and then moves on to look at the risks associated with asbestos exposure. Epidemiological and in vitro studies are then analyzed to determine the health risks of asbestos, with a specific focus on the different effects of serpentine and amphibole asbestos fibres. The paper then concludes with an analysis of Canadian policy in light of established scientific evidence and with a discussion of the possible implications of a gap between scientific knowledge and public policy.


  1. Chrysotile Institute. About the Institute. 2006.
  2. Health Canda. Inventory of Federal, Provincial and Territorial Environmental and Occupational Health Data Sources and
  3. Surveillance Activities. pubs/eval/inventory-repertoire/asbestON_e.html. 2003.
  4. Cudgell, D. W. and D. W. Kamp. Asbestos and Pleura. Chest 2004; 125: 1103-1117.
  5. Mossman, B.T., J. Bignon, M. Corn, A. Seaton and J.B.L. Gee. Asbestos: Scientific Developments and Implications for Public Policy. Science 1990; 247: 294-301.
  6. Sprince, N. L., L.C. Oliver, TC McLoud et al. Asbestos exposure and asbestos-related pleural and parenchymal disease:
  7. associations with immune imbalance. American Review of Respiratory Disorders 1991; 142: 843-847.
  8. Churg, A. Deposition and Clearance of Chrysotile Asbestos. British Occupational Hygiene Society 1994; 38(4): 625-633.
  9. Kamp, D.W. and S.A. Weitzman. The Molecular Basis of Asbestos Induced Lung Injury. Thorax 1999; 54: 638-652.
  10. Suzuki Y, Yuen SR, Ashley R. Short. Thin asbestos fibers contribute to the development of human malignant
  11. mesothelioma: pathological evidence. International Journal of Hygiene and Environmental Health 2005; 208(3): 201-10.
  12. Tweedale, G. and P. Hansen. Protecting the Workers: the Medical Board and the Asbestos Industry, 1930s-1960s. Medical
  13. History 1998; 42: 439-457.
  14. Health Canada. Health Effects of Chrysotile and other Asbestos Fibres in Support of the Consultation Document on the Addition of Chrysotile Asbestos to the PIC Procedure of the Rotterdam Convention. 2004.
  15. Freedman, B. Environmental Science. A Canadian Perspective, 4 ed. Toronto: Pearson Prentice Hall; 2007.
  16. Pedley, F. G. Asbestosis. Canadian Medical Association Journal, 253-254. 2005.
  17. Renner, Rebecca. Asbestos and Autoimmunity: More Bad News from Libby? Environmental Health Perspectives 2005; 113(1): 51.
  18. Polissar, L., R.K. Severson and E.S. Boatman. A Case-Control Study of Asbestos in Drinking Water and Cancer Risk. Journal of Epidemology 1984; 119(3):456-471.
  19. Webber J.S., M. Getman and T.J. Ward. Evidence and Reconstruction of Airborne Asbestos from Unconventional
  20. Environmental Samples. Inhalation Toxicology 2006; 18(12): 969-973.
  21. Anderson, B.A., S.M. Dearwent, J.T. Durant, J.J. Dyken, J.A. Freed, S.M. Moore and J.S. Wheeler. Exposure Pathway
  22. Evaluations for Sites that Processed Asbestos-Contaminated Vermiculite. International Journal of Hygiene and
  23. Environmental Health 2005; 208(1-2): 55-65.
  24. Berry, G., M.L. Newhouse and J.C. Wagner. Mortality from all Cancers of Asbestos Factory Workers in East London 1933-
  25. Occupational Environmental Medicine 2000; 57: 782-785.
  26. Pfau JC, Sentissi JJ, Weller G, Putnam EA. Assessment of autoimmune responses associated with asbestos exposure in
  27. Libby, Montana, USA. Environmental Health Perspectives 2005; 113(1):25-30.
  28. Tsang PH, Chu FN, Fischbein A, Bekesi JG. Impairments in functional subsets of T-suppressor (CD8) lymphocytes,
  29. monocytes, and natural killer cells among asbestos-exposed workers. Clin Immunol Immunopathol 1988; 47(3):323-332.
  30. Rosenthal, G. J., E. Corsini and P. Simeonova. Selected New Developments in Asbestos Immunotoxicity. Environmental
  31. Health Perspectives Supplements 1998; 106(1): 159-169.
  32. Sider, L., E.A. Holland, T.J. Davis and D.W. Cudgell. Changes on Radiographs of Wives of Workers Exposed to Asbestos.
  33. Radiological Society of North America 1987; 164: 723-726.
  34. Xu, A., H. Zhou, D.Z. Yu and T.K. Hei. Mechanisms of the Genotoxicity of Crocidolite Asbestos in Mammalian Cells:
  35. Implications from Mutation Patterns Induced by Reactive Oxygen Species. Environmental Health Perspectives 2002;
  36. (10): 1003-1008.
  37. Michiels, F.M., G. Moens, J.J. Montagne and I. Chouroulinkov. Biological Effects of Asbestos Fibres on Rat Lung Maintained in Vitro. Institute of Applied Research in Cancer 1989; 90: 156-160.
  38. Keane, M.J., J.W. Stephens, B.Z. Zhong, W.E. Miller, T.M. Ong and W.E. Wallace. A Study of the Effect of Chrysotile Fibre
  39. Surface Composition on Genotoxicity in Vitro. Journal of Toxicology and Environmental Health 1999; 57(8): 529-541.
  40. Bernstein, D.M. and J.A. Hoskins. The Health Effects of Chrysotile: Current Perspectives Based upon Recent Data.
  41. Regulatory Toxicology and Pharmacology 2006; 45(3): 252-264.
  42. Mossman, B.T. and A. Churg. Mechanisms in the Pathogenesis of Asbestosis and Silicosis. American Journal of Respiratory Critical Care Medicine 1998; 157(5): 1666-1680.
  43. Hessel, P.A., J.F. Gamble and J.C. McDonald. Asbestos, Asbestosis, and Lung Cancer: a Critical Assessment of the
  44. Epidemiological Evidence. Thorax 2005; 60: 433-436.
  45. Goldsmith, J.R. Asbestos as a systematic carcinogen: the evidence from eleven cohorts. American Journal of Clinical
  46. Pathology 1982; 80: 14-20.
  47. Kielkowski, D., G. Nelson and D. Rees. Risk of Mesothelioma from Exposure to Crocidolite Asbestos: a 1995 Update of a
  48. South African Mortality Study. Occupational Environmental Medicine 2000; 57: 563-567.
  49. Peto, J., A. Decarli, C. La Vecchia, F. Levi, E. Negri. The European Mesothelioma Epidemic. British Journal of Cancer
  50. ; 79(3-4): 666-672.
  51. McDonald, J.C. and A.D. McDonald. The Epidemiology of Mesothelioma in Historical Context. European Respiratory
  52. Journal 1996; 9: 1932-1942.
  53. McDonald, J.C., A.D. McDonald and J.M. Hughes. Chrysolite, Tremolite and Carcinogenicity. Annals of Occupational Hygiene 1997; 41(6): 699-705.
  54. Yazicioglu, S., R. Ilcayto, K. Balci, B.S.Sayli and B. Yorulmaz. Pleural Calcification, Pleural Mesotheliomas, and Bronchial
  55. Cancers Caused by Tremolite Dust. Thorax 1980; 35: 564-569.
  56. Davies, D., M.I. Andrews and J.S. Jones. Asbestos Induced Pericardial Effusion and Constrictive Pericarditis. Thorax 1991;
  57. : 429-432.
  58. Health Canada. Hazardous Materials Information System: Substance-Specific Issues. 2006.
  59. Government of Canada. Opening Doors to the World: Canada's International Market Access Priorities 2001. 2001
  60. Health Canda. Inventory of Federal, Provincial and Territorial Environmental and Occupational Health Data Sources and
  61. Surveillance Activities. 2003.
  62. Miller, A. Radiographic Readings for Asbestosis: Misuse of Science-Validation of the ILO Classification. American Journal
  63. for Industrial Medicine 2006; 50(1): 63-67.


Download data is not yet available.